Novartis International AG (CH) - Novartis sells US rights to the overactive bladder treatment Enablex
* Novartis to receive USD 400 million cash payment from Irish
based specialty pharmaceutical company Warner Chilcott
* Warner Chilcott to assume Enablex marketing, sales and
manufacturing for the US
Basel, September 24, 2010 - Novartis announced... (Source: Drugs.com - Pharma News)
CT/CTA a Practical Way to Assess Recurrent Stroke RiskCT/CTA a Practical Way to Assess Recurrent Stroke Risk
For hospitals that lack ready access to MRI, using CT/CT angiography to assess intra- and extracranial vasculature is a good way to predict risk of recurrent stroke. Medscape Medical News (Source: Medscape Today Headlines)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div
